Related Experiment Video
Updated: Jul 11, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Enhancing myocardial function with cardiac contractility modulation: potential and challenges
Zihan Li1,2, Qiming Liu1, Shenghua Zhou1
1Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.
Insights
Cardiac contractility modulation (CCM) is a new heart failure therapy for select patients. Further research is needed to confirm benefits and expand its use in diverse patient groups.
Area of Science:
- Cardiology
- Biomedical Engineering
- Heart Failure Management
Background:
- Cardiac contractility modulation (CCM) presents a novel therapeutic option for heart failure (HF) patients.
- CCM is particularly relevant for individuals unresponsive to cardiac resynchronization therapy (CRT) within specific QRS duration criteria.
- Existing research primarily focuses on left ventricular effects, leaving gaps in understanding CCM's impact on other patient subsets.
Purpose of the Study:
- To review the mechanistic basis of CCM.
- To evaluate CCM's effects on myocardial function and its applicability across various patient demographics.
- To identify limitations and areas for future research in CCM therapy.
Main Methods:
- Literature review of existing studies on Cardiac Contractility Modulation.
- Analysis of CCM's impact on myocardial function and patient outcomes.
- Identification of knowledge gaps and future research directions.
Main Results:
- CCM demonstrates potential as a therapeutic strategy for specific heart failure populations.
- Insufficient data currently exists regarding CCM's impact on mortality and hospitalization rates.
- Specialized skills are required for CCM device implantation, and research on left ventricular effects dominates.
Conclusions:
- CCM offers a promising avenue for heart failure treatment, but requires further investigation.
- Future studies should focus on mortality/hospitalization benefits, combinatory therapies, and atrial fibrillation's impact on implantation.
- Expanding research scope can refine CCM outcomes and broaden its patient applicability.
Abstract:
Cardiac contractility modulation (CCM) offers a novel therapeutic avenue for heart failure patients, particularly those unresponsive to cardiac resynchronization therapy within specific QRS duration ranges. This review elucidates CCM's mechanistic underpinnings, its impact on myocardial function, and utility across patient demographics. However, CCM is limited by insufficient data on mortality and hospitalization rate reductions, as well as the need for specialized device implantation skills. While prevailing research has concentrated on left ventricular effects, a knowledge gap persists for other patient subsets. Future inquiries should address combinatory treatment strategies, extended usage and the impact of atrial fibrillation on device implantation. Such expanded studies could refine therapeutic outcomes and widen the scope of beneficiaries.
Related Concept Videos
Pathophysiology of Cardiac Performance
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy VI: Nursing Management

